In the same study, in a breast cancer mouse model, the authors demonstrated that CD73 overexpression on tumor cells determines chemoresistance to anthracycline treatment, while the blockade of the enzyme improved antitumor immune response (Loi et al., 2013). The gene discussed is NT5E; the disease is breast cancer.